In a recent Economist article, Methylenedioxymethamphetamine (MDMA) has been rep
ID: 73543 • Letter: I
Question
In a recent Economist article, Methylenedioxymethamphetamine (MDMA) has been reported to have significant therapeutic effects for the treatment of PTSD. Will its classification as a Schedule I drug increase the likelihood of it being approved for use as a therapeutic agent?
Yes, Schedule I drugs are the least restrictive drugs
No, Schedule I drugs are the least restrictive drugs
No, Schedule I drugs are the most restrictive drugs
Yes, Schedule I drugs are the most restrictive drugs
Its classification as a Schedule I drug will not affect its likelihood of being used as a therapeutic agent since all legal drugs have to be classified as Schedule I to be prescribed.
A.Yes, Schedule I drugs are the least restrictive drugs
B.No, Schedule I drugs are the least restrictive drugs
C.No, Schedule I drugs are the most restrictive drugs
D.Yes, Schedule I drugs are the most restrictive drugs
E.Its classification as a Schedule I drug will not affect its likelihood of being used as a therapeutic agent since all legal drugs have to be classified as Schedule I to be prescribed.
Explanation / Answer
Though, Methylenedioxymethamphetamine ( MDMA) is having a effect in treating the Post-Traumatic Stress Disorder It is causing a sever damage to the central nerveous system so there might not be increase in the likelihood of it being to be used as therapeutic agent.
Related Questions
drjack9650@gmail.com
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.